Key result
Same-day discharge after elective M-TEER shows similar 30-day mortality and HF readmission vs next-day discharge.
Why the study?
The safety of same-day discharge following mitral transcatheter edge-to-edge repair (M-TEER) in a nationwide setting remains unclear.
Does same-day discharge compared to next-day discharge affect the composite of 30-day mortality and HF readmission in Medicare beneficiaries undergoing elective M-TEER?
Cohort (n=12,048)
Yes
Does same-day discharge compared to next-day discharge affect the composite of 30-day mortality and HF readmission in Medicare beneficiaries undergoing elective M-TEER?
Same-day discharge after elective M-TEER appears safe, with no significant difference in 30-day mortality or heart failure readmission compared to next-day discharge.
Answers are grounded in this paper and cite their sources.
May support same-day discharge after mitral TEER in select patients; leaves open confirmation via larger randomized trials.
BACKGROUND The safety of same-day discharge following mitral transcatheter edge-to-edge repair (M-TEER) in a nationwide setting remains unclear. METHODS Using the administrative databases on Medicare fee-for-service beneficiaries, we identified patients aged 65-99 years undergoing elective M-TEER from 2016 to 2021 and who were discharged home on the same day or the next day after the procedure. We applied a linear probability model to examine the relationship between same-day discharge and patient outcomes, adjusting for patient demographics, underlying comorbidities, and hospital fixed effects (effectively comparing outcomes within the same hospital). The primary outcome was the composite of 30-day mortality and heart failure (HF) readmission. RESULTS Of the total of 12,048 patients, 137 (1.1%) patients were discharged on the same day as the procedure. We did not find a statistically significant difference in the risk of the primary outcome [same-day discharge versus next-day discharge; adjusted risk difference (aRD), -1.0% points (pp); 95% confidence interval (CI), -2.8 to +0.8]. Similarly, we did not find significant differences between the two groups in 30-day mortality (aRD, -0.6 pp.; 95% CI, -2.0 to +0.9) and HF readmission (aRD, -0.5 pp.; 95% CI, -1.6 to +0.6). CONCLUSIONS In this study, we did not find evidence that the risk of 30-day mortality and HF readmission differed between same-day discharge and next-day discharge following M-TEER. Further investigations are needed to clarify who warrants prolonged observation after the procedures.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2026) conducted a cohort in Elective mitral transcatheter edge-to-edge repair (M-TEER) (n=12,048). Same-day discharge vs. Next-day discharge was evaluated on Composite of 30-day mortality and heart failure (HF) readmission (aRD -1.0 pp, 95% CI -2.8 to +0.8). Same-day discharge after elective M-TEER showed no significant difference in 30-day mortality and heart failure readmission compared to next-day discharge (aRD -1.0 pp; 95% CI -2.8 to +0.8).
Synapse has enriched 10 related papers. Consider them for comparative context: